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Effect of equisetum arvense extract on bone mineral 
density in Wistar rats via digital radiography 
 
 
Abstract 
Background: Osteoporosis is a common disease of old age. The present study used digital 
radiography to determine the effects of equisetum arvense extract on the bone mineral 
density (BMD) of experimental rats. 
Methods: In this experimental study, 25 male and 25 female Wistar rats, aged three weeks 
old and weighing 100 grams, were randomly divided into five groups: (1) control group, 
(2) calcium/vitamin D group, (3) 60 mg/kg equisetum arvense extract group, (4) 90 mg/kg 
equisetum arvense extract group and (5) 120 mg/kg equisetum arvense extract group. Rats 
received these diets for 30 days. The spongy bone density was measured in the maxilla and 
mandible using digital radiography and the serum levels of calcium, vitamin D and 
phosphorus were measured at baseline and after 30 days. The data were analyzed using 
ANOVA and Tukey test. 
Results: There was no significant difference between serum calcium and phosphorus 
levels in the five groups before and after 30 days. The serum vitamin D in the group 
receiving calcium and vitamin D was significantly higher than in the other groups (with 
average values of 24.7, 61.7, 23.47, 23.95 and 39.16 in the male groups 1 to 5 and 29.0, 
85.07, 31.58, 42.34 and 18.83 in the female groups 1 to 5, respectively (p<0.001). 
Moreover, the increased mandibular BMD in the 120 mg/kg equisetum arvense group was 
significantly higher than in the control group (p<0.01). 
Conclusion: A diet containing 120 mg/kg equisetum arvense extract resulted in increased 
mandibular bone mineral density. 
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Achieving peak bone mass is necessary to attain optimal bone health and, hence, 
reduce the risk of osteoporosis in the future (1). The achievement of peak bone mass will 
continue until late adolescence or the early 20s (2), depending on the interactions between 
hormones and growth factors, genetics, physical activity and nutrition, particularly calcium 
and vitamin D (3-5). Bone mineral density (BMD) can be altered by various factors, such 
as diet, age and the use of chemical and natural medicines. Osteoporosis is a bone disease 
characterized by the loss of bone and its structural deterioration. The manifestations of this 
disease include a reduction in bone mineral content and bone matrix, thus, although the 
bone is completely normal in terms of the compounds, it is reduced in terms of its content. 
The reduction of bone mass that occurs in this disease leads to an imbalance between bone 
loss and its formation and eventually results in demineralization. Osteoporosis causes pain 
and deformity or bone fractures due to the demineralization of the bone. 
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Today, much attention is paid to the use of traditional and 
herbal medicines in the treatment of diseases and, at the 
same time, researchers attempt to determine the results of 
using these medicines through standard laboratory 
techniques. Equisetum arvense is a native plant of the 
Northern Hemisphere that grows in Europe, South Asia, the 
Himalayas and in countries such as Canada, the United 
States, Iran, Turkey, India, Korea and Japan (6).  
The use of equisetum arvense is a suitable approach to 
the treatment of osteoporosis because it contains a significant 
amount of silica and its consumption leads to the absorption 
and use of calcium and the formation of collagen (4). Due to 
having factors and compounds such as alkaloids, 
phytosterols, tannin, triterpenoids and phenolics, equisetum 
arvense is also effective in preventing bone loss that is 
caused by age and estrogen deficiency (7). In addition to 
silica, equisetum arvense contains secondary metabolites, 
such as quercetin, kaempferol, luteolin, apigenin, oleanolic 
acid, betulinic acid and ursolic acid, all of which affect the 
anabolic activity of osteoblasts (4). In addition, the silica in 
this plant results in the formation of bone and connective 
tissue by facilitating the deposition of calcium and other 
minerals, decreasing the number of osteoclast cells, 
stimulating the activity of osteoblasts, stimulating collagen 
synthesis and facilitating the synthesis of glycosaminoglycan 
and collagen. Despite these effects, few studies have 
evaluated the results of the effect of equisetum arvense in the 
treatment and prevention of osteoporosis and further research 
is required in this regard (8). Therefore, it may be possible to 
use equisetum arvense in the treatment of osteoporosis.  
Given the possibility of examining BMD on images 
through the use of related software and given its lower cost 
and availability, digital imaging is currently an appropriate 
option for assessing bone mineral density which has been 
used in several previous studies (9, 10).  
The main aim of the presented study was to determine 
the effects of equisetum arvense extract on BMD and 
calcium and phosphorus levels in rats. However, what makes 
this study different from the research conducted by Kotwal 
and Badole (2016) is that, this research seeks to investigate 
the impact of equisetum arvense on bone density using 
radiography, not histopathology methods, as this method of 
evaluation is cheap, simple, effective, and accurate. In 
addition to radiographic methods, blood samples are also 
taken from specimens to evaluate the amount of calcium and 
phosphorus levels in rats.  
Methods 
This experimental study was approved by the Babol 
University of Medical Sciences Ethics Committee (code no: 
MUBABOL.HRI.REC.1396.135). A voucher specimen 
(0011540) was prepared and is held in the herbarium, 
Department of Pharmacology, Babol University of Medical 
Sciences. To prepare the specimens, the upper part of the 
horsetail plant was separated and then waste parts were 
removed. The rest of the plant was washed and dried in 
shade and powdered by an electric mill. The dried horsetail 
powder was mixed with 70% ethanol and then placed in a 
shaker for 72 hours. After that, the solution was transferred 
from filter paper and the hydro alcoholic extract was 
transferred to the rotary evaporator and the solvent was 
removed. The present study was carried out to study the 
effect of extract of equisetum arvense in Wistar rats at three 
levels of dose: L (30 mg/ kg of body weight), M (60 mg/ kg 
of body weight) and H (120 mg/ kg of body weight) for a 
period of 30 days, to determine the range of therapeutic dose 
to be used for the further studies.  
Wistar rats (25 males and 25 females) aged three weeks 
old and weighing 100 grams were prepared. Each group of 
25 male and female rats was randomly divided into five 
groups of five and each of the five rats was placed is a cage. 
Both male and female rats have been used for this study to 
show if there is any significant difference in BMD changes 
regarding the gender of wistar rats. The study groups 
included:    
Group 1: Control group with daily diet 
Group 2: Daily diet plus 200 mg/kg calcium/vitamin D 
Group 3: Daily diet plus 60 mg/kg equisetum arvense extract  
Group 4: Daily diet plus 90 mg/kg equisetum arvense extract  
Group 5: Daily diet plus 120 mg/kg equisetum arvense 
extract.  
Equisetum arvense extract and calcium/vitamin D were 
given by gavage. 
The five groups of rats were then kept at a temperature of 
24°C for 30 days under a 12:12 h light-dark cycle in a room 
with similar conditions and in separate stainless steel cages 
of a standard size. The first group received the usual daily 
diet. The second group, as a positive control, received 
calcium and vitamin D in addition to the normal daily diet. 
Groups three to five received equisetum arvense extract by 
gavage in addition to the normal daily diet.  
Blood sampling was used to evaluate the effects of 
equisetum arvense on calcium and vitamin D at baseline and 
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after 30 days, while the changes of BMD were investigated 
using radiography. The following discuss these two different 
methods in more details. 
Blood sampling: Blood samples were collected from all of 
the rats at baseline and at the end of the study. Several 2 cc 
blood samples were collected from the eyes of the rats using 
a capillary tube. In the laboratory, the blood samples were 
placed in a centrifuge device for eight minutes to separate 
the serum from the blood. The isolated serum was then 
placed in 2 cc tubes prepared for each animal. For 
radiography, the rats were first anesthetized with an 
intraperitoneal injection of 2 ml ketamine (100 mg/ml) and 1 
ml of xylazine (20 mg/ml). Blood samples were collected 
again after 30 days and the calcium, phosphorus and vitamin 
D levels were measured using an ELISA kit (IDS company 
for vitamin D and Pars Azmoon for calcium and phosphorus). 
Radiography: Radiographs of the rats’ heads were then 
taken using a digital phosphor storage plate (PSP) sensor 
(occlusal size) in such a way that the lateral image of the jaw 
could be obtained. The radiographs were taken using a Pro X 
digital dental imaging device (Planmeca-Helsinki, Finland) 
under similar conditions in terms of the peak voltage (50 
kVp), amperage (8 mA), the distance between the rats and 
the x-ray tube (50 cm) and the time (0.50 s).  
The PSPs were then processed using PCT (Soredex - 
Helsinki, Finland) and the spongy bone density was 
measured at five points for each jaw using Digora for 
Windows (DfW 2.7). The obtained average value was 
recorded, as shown in figure 1. In previous studies, this 
instrument has been frequently used in the evaluation of 
bone density in small animals such as rats (10-14). 
 
 
 
 
 
 
 
 
 
Figure 1: The measurement of rats’ maxillary and 
mandibular BMD using Radiography 
 
The rats were then anesthetized with ketamine and 
xylazine and their maxillary and mandibular BMD was 
measured and recorded using radiography at baseline and 
after 30 days, as shown in figure 1. Finally, the data were 
analyzed using SPSS Version 17, the ANOVA test and 
Tukey’s post-hoc test.  
 
 
Results 
The effective compounds of extract were determined 
using a chemical fingerprint, as shown in table 1. 
Furthermore, a GC-MS test was done to investigate the 
content of these active compounds (figure 2).  
Based on the gender of the rats, table 2 shows the mean 
calcium, phosphorus and vit D levels and the maxillary and 
mandibular bone mineral densities in the control group, the 
calcium/vit D group and the groups with different 
concentrations of equisetum arvense extract at baseline and 
at the end of the study. Tables 3 and 4 present the results of a 
pairwise comparison between the groups in terms of changes 
in serum vitamin D and their mandibular BMD before and 
after consumption of the nutritional diets. The differences in 
the levels of serum vitamin D before and after 30 days in the 
control and calcium/vitamin D groups (p<0.001), 
calcium/vitamin D and 60 mg/kg equisetum arvense groups 
(p<0.001), calcium/vitamin D and 90 mg/kg equisetum 
arvense groups (P<0.001) and calcium/vitamin D and 120 
mg/kg equisetum arvense groups (p<0.001) were statistically 
significant (p<0.001). In addition, there was a significant 
difference in the values of the mandibular BMD in the 
control and the 120 mg/kg equisetum arvense groups 
(p<0.01), but no significant changes were observed in the 
other groups. 
 
Table 1: The main components of equisetum arvense 
obtained from a chemical fingerprint 
Peak 
R.T. 
min 
Chemical name 
% of 
total 
1 9.696 2-Furancarboxaldehyde 6.093% 
2 11.390 5-Hydroxymethylfurfural 27.032% 
3 13.295 4-(Ethoxymethyl)phenol 1.365% 
4 14.382 ursolic acid 32.918% 
5 22.370 1-Oxaspiro[2.5]oct-5-ene 2.508% 
6 25.574 oleanolic acid 10.855% 
7 26.072 betulinic acid 3.624% 
8 27.926 Borane 2.075% 
9 33.517 Phosphorus trifluoride 2.222% 
10 34.180 Bis(2-ethylhexyl) phthalate 2.772% 
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Figure 1: The results of GC-MS test 
 
Table 2: Mean levels of BMD and serum calcium, vit D and phosphorus levels before and after 30 days, based on gender
After 30 days At baseline 
Group Mandibular 
BMD 
Maxillary 
BMD 
Vitamin D P Calcium 
Mandibular 
BMD 
Maxillary 
BMD 
Vitamin D P 
Ca 
 
196.85±2.66 177.5 ± 6.76 24.7 ± 5.88 7.58±0.92 9.03±0.31 189.28 ± 3.3 173.12±5.54 25.85±13.2 9.42±0.52 8.88±0.96 Male, control* 
188.0 ± 2.18 168.0±3.81 63.54±18.76 7.04±0.65 8.86±0.29 188.2 ± 1.79 171.52±2.46 28.62±1.82 10.32±0.49 9.76 ±0.33 Female, control* 
198.85±2.16 175.25±2.92 61.7 ± 15.85 7.35±0.42 8.93±0.13 185.2 ± 2.87 170.12±2.66 18.4 ± 3.23 10.85±0.66 9.93 ±0.28 
Male, 
Calcium/VitaminD* 
195.4 ± 3.59 174.04±2.09 52.07±45.35 6.43±0.35 8.95±0.13 188.1 ± 3.13 174.6 ±6.43 29.75±6.93 9.18±0.94 9.88±0.31 
Female, 
Calcium/VitaminD* 
196.44±1.86 170.28±2.46 23.47 ± 6.49 8.6 ± 1.66 9.47±0.25 184.64 ± 3.04 167.56±1.69 24.9±12.39 10.03±0.05 10.35±0.3 
Male, 60 mg/kg 
Equisetum Arvense 
193.44±3.31 171.36±4.34 31.58 ± 8.51 6.78±0.54 8.56±0.52 187.68 ± 2.0 168.88±1.22 23.04±1.99 9.62±0.43 10.14±0.75 
Female, 60 mg/kg 
Equisetum Arvense 
198.7 ± 5.18 176.5 ± 4.87 23.95 ± 8.43 7.88±0.22 8.73±0.43 182.84 ± 2.64 169.88±1.72 18.72±1.92 9.62±0.97 10.06±0.55 
Male, 90 mg/kg 
Equisetum Arvense 
195.0 ± 4.07 174.3 ± 1.55 42.34 ± 4.23 6.32±0.65 9.18±0.28 190.32 ± 2.99 173.56±2.74 28.16±6.87 10.22±0.84 9.22±0.31 
Female, 90 mg/kg 
Equisetum Arvense 
193.36±3.21 169.6 ± 1.91 39.16 ± 4.98 6.78±0.73 8.42±0.56 177.56 ± 4.32 161.4±6.62 32.02 ± 4.1 9.78±0.76 9.18±0.28 
Male, 120 mg/kg 
Equisetum Arvense 
197.4±13.03 179.0±17.03 18.83 ± 0.29 8.77±0.55 8.93±0.25 178.52 ± 3.64 163.52±3.95 28.32±7.69 9.97±1.11 9.2 ±0.51 
Female, 120 mg/kg 
Equisetum Arvense 
* These groups are shared with a research project (code no: 964505) conducted at the Babol University of Medical Sciences. 
The mean levels maxillary and mandibular BMD at 
baseline and after 30 days are shown in figures 3 and 4. 
According to the results of the Tukey test, the mean 
difference in serum vitamin D in the calcium/vitamin D 
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group was significantly higher than in the control group and 
the groups receiving equisetum arvense extract (p<0.05). 
The maxillary BMD decreased in animals receiving 60 and 
90 mg/kg equisetum arvense in comparison with the control 
group and the group receiving calcium/vitamin D but these 
reductions were not significant and an increase in 120 mg/kg 
equisetum arvense group was not significant.  
 
 
 
 
 
 
 
 
 
 
 
Figure 3: The mean levels of mandibular BMD at 
baseline and after 30 days 
With regard to the mandibular BMD, only the density in 
the 120 mg/kg equisetum arvense group was significantly 
higher than the control group (p<0.05) but the BMD changes 
were not significant in the other groups. With regard to the 
mandibular BMD based on gender, the density in males and 
females and in the animals in the 120 mg/kg equisetum 
arvense group increased compared to the control group and 
the group receiving calcium/vitamin D and this increase was 
only significant in comparison with the female control group 
(p<0.05). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: The mean levels of maxillary BMD at baseline 
and after 30 days 
 
Table 3: Mean and standard error of changes in vitamin D levels 
P-value Standard error Mean changes Second group First group 
0.001 5.35 21.51 Calcium/Vitamin D Control 
NS 5.16 12.78 60 mg/kg Equisetum Arvense Control 
NS* 5.0 11.19 90 mg/kg Equisetum Arvense Control 
NS 5.16 12.83 120 mg/kg Equisetum Arvense Control 
0.001 5.49 34.29 60 mg/kg Equisetum Arvense Calcium/Vitamin D 
0.001 5.35 32.7 90 mg/kg Equisetum Arvense Calcium/Vitamin D 
0.001 5.49 34.34 120 mg/kg Equisetum Arvense Calcium/Vitamin D 
NS 5.16 1.59 90 mg/kg Equisetum Arvense 60 mg/kg Equisetum Arvense 
NS 5.31 0.05 120 mg/kg Equisetum Arvense 60 mg/kg Equisetum Arvense 
NS 5.16 1.64 120 mg/kg Equisetum Arvense 90 mg/kg Equisetum Arvense 
*= Not significant 
Table 4: Mean and standard error of changes in the mandibular BMD of rats  
P-value Standard error Mean changes Second group First group 
NS
* 
3.59 6.37 Calcium/Vitamin D Control 
NS 3.4 4.45 60 mg/kg Equisetum Arvense Control 
NS 3.59 5.22 90 mg/kg Equisetum Arvense Control 
0.01 3.48 13.16 120 mg/kg Equisetum Arvense Control 
NS 3.5 1.92 60 mg/kg Equisetum Arvense Calcium/Vitamin D 
NS 3.69 1.15 90 mg/kg Equisetum Arvense Calcium/Vitamin D 
NS 3.59 6.79 120 mg/kg Equisetum Arvense Calcium/Vitamin D 
NS 3.5 0.77 90 mg/kg Equisetum Arvense 60 mg/kg Equisetum Arvense 
NS 3.4 8.71 120 mg/kg Equisetum Arvense 60 mg/kg Equisetum Arvense 
NS 3.59 7.94 120 mg/kg Equisetum Arvense 90 mg/kg Equisetum Arvense 
*= Not significant 
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Discussion 
According to the research conducted by previous authors, 
ursolic acid (32.918%) and oleanolic acid (10.855%) 
extracted in equisetum arvense can improve bone properties, 
calcium balance, and modulate vitamin D metabolism. 
Ursolic acid and oleanolic acid have been reported to 
stimulate osteoblastic differentiation and inhibit osteoclast 
formation in vitro (15, 16).  
The mandibular BMD in the 120 mg/kg equisetum 
arvense group was significantly higher than in the control 
group but there were no significant differences when 
compared with the other groups. In addition, the BMD 
increased in both male and female subjects and in the 120 
mg/kg equisetum arvense group compared to the control 
group and the group receiving calcium/vit D. This increase 
was only significant compared to the control group of female 
animals. There was no significant difference in the serum 
calcium and phosphorus levels and the mean difference at 
the baseline and after 30 days. However, the mean difference 
in serum vitamin D in the group receiving calcium/vit D was 
significantly higher than the control group and the groups 
receiving equisetum arvense extract.  
The decrease in the serum calcium levels is due to 
increased calcium excretion and reduced absorption in the 
body. Silica can increase bone mineralization by reducing 
the rate of calcium excretion. However, the reduction in the 
serum calcium levels of the animals receiving a normal diet 
along with equisetum arvense extract was not significant and 
acceptable in the present study. In the study of Kotwal and 
Badole (2016), the use of equisetum arvense extract did not 
significantly change the serum calcium levels, which is 
consistent with the results of the present study (3). In this 
study, the highest serum vit D levels were observed in 
animals receiving a calcium/vit D diet and the increase in the 
serum vit D levels in animals receiving calcium/vit D was 
significantly higher in the control group and the 60, 90 and 
120 mg/kg equisetum arvense groups. Therefore, receiving 
different concentrations of equisetum arvense extract has a 
lower effect on increasing the serum vit D levels compared 
to the usual calcium/vit D diet. However, it is necessary to 
evaluate other concentrations of the plant in this field and to 
report the results. 
In the study conducted by Kotwal and Badole (2016), the 
increase in the thickness of the cortical and cancellous bones 
in the group receiving equisetum arvense extract (which was 
also evident in histological observations), indicates the bone 
mineralization ability and activity of the plant (3). 
Meanwhile, the use of calcium and vit D supplements, along 
with equisetum arvense, decreased osteoporosis. In the 
present study, the consumption of equisetum arvense extract, 
especially at a concentration of 120 mg/kg, increased the 
mandibular and maxillary BMD. On the other hand, an 
investigation by Menghini et al. (2016) of the effects of 
using a natural formulation containing lactoferrin, equisetum 
arvense soy isoflavone and vit D3 in bone remodeling and 
inflammatory markers in rats demonstrated that this 
formulation was useful in preventing and treating 
osteoporosis (2).  
Furthermore, Corletto (1999) investigated the absorption 
rate of silicone from an equisetum arvense diet in 
postmenopausal women who suffered from osteoporosis. 
The results of the study showed that treatment with 
equisetum arvense extract and calcium supplements were 
effective in improving bone metabolism (8). These 
observations were also reported in the present study on 
equisetum arvense extract, especially at a concentration of 
120 mg/kg.  
In conclusion, the objective of the present work was to study 
the effect of extract of equisetum arvense in wistar rats at 
three levels of dose: L (30 mg/ kg of body weight), M (60 
mg/ kg of body weight) and H (120 mg/ kg of body weight) 
for a period of 30 days, to determine the range of therapeutic 
dose to be used for the further studies. 
This study found that 120 mg/kg equisetum arvense 
extract resulted in a significant increase in mandibular BMD 
but the BMD changes were not significant in the other 
groups. With regard to the mandibular BMD based on 
gender, the density in males and females and in the animals 
in the 120 mg/kg equisetum arvense group increased 
compared to the control group and the group receiving 
calcium/vitamin D and this increase was only significant in 
comparison with the female control group. . However, there 
is still a need for further studies on equisetum arvense extract 
at other concentrations. 
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